169 related articles for article (PubMed ID: 38322287)
1. Neoadjuvant short-course radiotherapy or chemoradiation plus consolidative chemotherapy followed by radical operation for locally advanced rectal cancer.
Lee SF; Yip PL; Wo B; Wong NS; Vellayappan BA; Mamon HJ; Lee FAS
Front Oncol; 2023; 13():1284569. PubMed ID: 38322287
[TBL] [Abstract][Full Text] [Related]
2. A systematic review and network meta-analysis of randomised controlled trials comparing neoadjuvant treatment strategies for stage II and III rectal cancer.
Simillis C; Khatri A; Dai N; Afxentiou T; Jephcott C; Smith S; Jadon R; Papamichael D; Khan J; Powar MP; Fearnhead NS; Wheeler J; Davies J
Crit Rev Oncol Hematol; 2023 Mar; 183():103927. PubMed ID: 36706968
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of Total Neoadjuvant Therapy With Short-Course Radiotherapy for Resectable Locally Advanced Rectal Cancer.
Chin RI; Otegbeye EE; Kang KH; Chang SH; McHenry S; Roy A; Chapman WC; Henke LE; Badiyan SN; Pedersen K; Tan BR; Glasgow SC; Mutch MG; Samson PP; Kim H
JAMA Netw Open; 2022 Feb; 5(2):e2146312. PubMed ID: 35103791
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness analysis of long-course oxaliplatin and bolus of fluorouracil based preoperative chemoradiotherapy vs. 5x5Gy radiation plus FOLFOX4 for locally advanced resectable rectal cancer.
Wang S; Wen F; Zhang P; Wang X; Li Q
Radiat Oncol; 2019 Jun; 14(1):113. PubMed ID: 31234886
[TBL] [Abstract][Full Text] [Related]
5. Comparison of pathological complete response rates after neoadjuvant short-course radiotherapy or chemoradiation followed by delayed surgery in locally advanced rectal cancer.
Hoendervangers S; Couwenberg AM; Intven MPW; van Grevenstein WMU; Verkooijen HM
Eur J Surg Oncol; 2018 Jul; 44(7):1013-1017. PubMed ID: 29650419
[TBL] [Abstract][Full Text] [Related]
6. Dose escalation of preoperative short-course radiotherapy followed by neoadjuvant chemotherapy in locally advanced rectal cancer: protocol for an open-label, single-centre, phase I clinical trial.
Zhang MX; Li XB; Guan BJ; Guan GX; Lin XY; Wu XD; Chi P; Xu BH
BMJ Open; 2019 Mar; 9(3):e025944. PubMed ID: 30904869
[TBL] [Abstract][Full Text] [Related]
7. Five-year oncological outcomes after selective neoadjuvant radiotherapy for resectable rectal cancer.
Banwell VC; Phillips HA; Duff MJ; Speake D; McLean C; Williams LJ; He Y; Paterson HM
Acta Oncol; 2019 Sep; 58(9):1267-1272. PubMed ID: 31237192
[No Abstract] [Full Text] [Related]
8. [Application of short-course radiotherapy with total neoadjuvant therapy in the treatment of middle and low rectal cancer].
Chen CJ; Yang CK; Jian JL; Guan S; Xie MM
Zhonghua Yi Xue Za Zhi; 2023 Jan; 103(4):271-277. PubMed ID: 36660788
[No Abstract] [Full Text] [Related]
9. Preoperative short-course radiotherapy followed by consolidation chemotherapy for treatment with locally advanced rectal cancer: a meta-analysis.
Wu H; Fan C; Fang C; Huang L; Li Y; Zhou Z
Radiat Oncol; 2022 Jan; 17(1):14. PubMed ID: 35073940
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant short-course radiotherapy with consolidation chemotherapy for locally advanced rectal cancer: a systematic review and meta-analysis.
Patel A; Spychalski P; Corrao G; Jereczek-Fossa BA; Glynne-Jones R; Garcia-Aguilar J; Kobiela J
Acta Oncol; 2021 Oct; 60(10):1308-1316. PubMed ID: 34308767
[TBL] [Abstract][Full Text] [Related]
11. Total Neoadjuvant Therapy in Rectal Cancer: Multi-center Comparison of Induction Chemotherapy and Long-Course Chemoradiation Versus Short-Course Radiation and Consolidative Chemotherapy.
Moyer AM; Vogel JD; Lai SH; Kim H; Chin RI; Moskalenko M; Olsen JR; Birnbaum EH; Silviera ML; Mutch MG; Chapman BC
J Gastrointest Surg; 2023 May; 27(5):980-989. PubMed ID: 36759387
[TBL] [Abstract][Full Text] [Related]
12. Pathologic Response and Postoperative Complications After Short-course Radiation Therapy and Chemotherapy for Patients With Rectal Adenocarcinoma.
Avila S; Chang GJ; Dasari NA; Smani DA; Das P; Herman JM; Koay E; Koong A; Krishnan S; Minsky BD; Smith GL; Taniguchi C; Taggart MW; Kaur H; Holliday EB
Clin Colorectal Cancer; 2020 Jun; 19(2):116-122. PubMed ID: 32173279
[TBL] [Abstract][Full Text] [Related]
13. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial.
Bahadoer RR; Dijkstra EA; van Etten B; Marijnen CAM; Putter H; Kranenbarg EM; Roodvoets AGH; Nagtegaal ID; Beets-Tan RGH; Blomqvist LK; Fokstuen T; Ten Tije AJ; Capdevila J; Hendriks MP; Edhemovic I; Cervantes A; Nilsson PJ; Glimelius B; van de Velde CJH; Hospers GAP;
Lancet Oncol; 2021 Jan; 22(1):29-42. PubMed ID: 33301740
[TBL] [Abstract][Full Text] [Related]
14. Short-Term Outcomes and Cost-Effectiveness between Long-Course Chemoradiation and Short-Course Radiotherapy for Locally Advanced Rectal Cancer.
Cho MS; Bae HW; Chang JS; Yang SY; Kim TH; Koom WS; Shin SJ; Choi GS; Kim NK
Yonsei Med J; 2023 Jun; 64(6):395-403. PubMed ID: 37226566
[TBL] [Abstract][Full Text] [Related]
15. Short course radiotherapy and delayed surgery for locally advanced rectal cancer in frail patients: is it a valid option?
Lancellotti F; Solinas L; Sagnotta A; Mancini S; Cosentino LPM; Belardi A; Battaglia B; Mirri MA; Ciabattoni A; Salerno F; Loponte M
Eur J Surg Oncol; 2021 Aug; 47(8):2046-2052. PubMed ID: 33757649
[TBL] [Abstract][Full Text] [Related]
16. Current status of neoadjuvant therapy for locally advanced rectal cancer in Wuhan Union Hospital Cancer Center.
Zhai ML; Zhang FY; Yang JR; Zhang S; Zhao L; Lin ZY; Wang J; Yu DD; Zhang T
Radiat Oncol; 2022 Jun; 17(1):109. PubMed ID: 35718789
[TBL] [Abstract][Full Text] [Related]
17. Effect of short-course radiotherapy followed by oxaliplatin-based consolidation chemotherapy on organ preservation in locally advanced rectal cancer.
Liao CK; Kuo YT; Hsu YJ; Chern YJ; Yu YL; Lin YC; Hsieh PS; Chiang JM; Yeh CY; You JF
Int J Colorectal Dis; 2023 Apr; 38(1):92. PubMed ID: 37022513
[TBL] [Abstract][Full Text] [Related]
18. [Short-course radiotherapy combined with CAPOX and PD-1 inhibitor for the total neoadjuvant therapy of locally advanced rectal cancer: the preliminary single-center findings of a prospective, multicentre, randomized phase II trial (TORCH)].
Wang YQ; Shen LJ; Wan JF; Zhang H; Wang Y; Wu X; Wang JW; Wang RJ; Sun YQ; Tong T; Huang D; Wang L; Sheng WQ; Zhang X; Cai GX; Xu Y; Cai SJ; Zhang Z; Xia F
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 May; 26(5):448-458. PubMed ID: 37217353
[No Abstract] [Full Text] [Related]
19. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M;
JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003
[TBL] [Abstract][Full Text] [Related]
20. Short-course radiotherapy combined with CAPOX and Toripalimab for the total neoadjuvant therapy of locally advanced rectal cancer: a randomized, prospective, multicentre, double-arm, phase II trial (TORCH).
Wang Y; Shen L; Wan J; Zhang H; Wu R; Wang J; Wang Y; Xu Y; Cai S; Zhang Z; Xia F
BMC Cancer; 2022 Mar; 22(1):274. PubMed ID: 35291966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
